Compare COTI (COTI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
COTI vs Enzyme — how do they compare? COTI trades at Rp141.25 (market cap Rp413,37M, Rp38,35M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: COTI is far larger — about 3.1× Enzyme's market cap, and COTI's supply is capped (2,9B / 4,9B COTI (60%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold COTI for 120 Days and Enzyme for 28 Days on average.
| COTI | MLN | |
|---|---|---|
Market Cap | Rp413,37M | Rp134,13M |
Volume (24h) | Rp38,35M | Rp104,56M |
Circulating Supply | 2,9B / 4,9B COTI (60%) | 3,3M MLN |
Typical Hold Time | 120 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
COTI is currently trading at Rp140.54 with a bearish technical outlook, showing strong selling pressure across moving averages and neutral oscillators. The token trades near key support levels with 60% of its 4.9M max supply in circulation. Recent technical indicators show RSI levels in neutral territory while ADX signals selling momentum. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and limited fundamental catalysts. Investors should monitor for any protocol updates or exchange listing developments that could impact sentiment.
Enzyme (MLN) shows a market cap of Rp134,13M with a circulating supply of 3,3jt tokens. The asset's price data is currently unavailable, but the hold time of 28 days suggests moderate trader retention. Recent news on ETF inflows may indirectly affect crypto sentiment, though no direct protocol updates are noted. Trading volumes and network activity metrics require verification from live crypto data sources for a complete picture.
Outlook: Enzyme faces typical crypto volatility risks with limited recent fundamental developments. Opportunities may arise from broader market trends, but investors should monitor liquidity and regulatory shifts closely. Major risks include low market cap susceptibility to manipulation and absence of max supply clarity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About COTI
COTI markets itself as the first enterprise-grade fintech platform that empowers organizations to build their own payment solutions as well as digitize any currency to save time as well as money. It is one of the world’s first blockchain protocols that is optimized for decentralized payments and designed for use by merchants, governments, payment DApps, and stablecoin issuers.
Read more on COTI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
